drugset / Trial / NCT02518932
The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man
Phase 1
Unknown
20 enrolled
Elahi, Dariush, PhD
ICON plc · collabMassachusetts General Hospital · collabNational Institute on Aging (NIA) · collab
RandomizedCrossoverSingle-blindSupportive care
Summary
To asses the modulating properties of the cleaved pentapeptide product of GLP-1 amide.
Timeline
- Start
- 2015-03
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VTC-G15 | Unknown | — | — |
Indications
No indication recorded.